PBLA
Panbela Therapeutics, Inc. Common Stock
PBLA
PBLA
Delisted
PBLA was delisted on the 6th of March, 2024.
11 hedge funds and large institutions have $564K invested in Panbela Therapeutics, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 0 closing their positions.
Holders
11
Holders Change
+4
Holders Change %
+57.14%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
Goldman Sachs
New York
|
$449K |
2 |
HF
2
HRT Financial
New York
|
$34K |
3 |
![]()
3
JPMorgan Chase & Co
New York
|
$11.4K |
4 |
TSS
4
Two Sigma Securities
New York
|
$10.7K |
5 |
TRCT
5
Tower Research Capital (TRC)
New York
|
$13.7K |
Top Sellers
1 |
1
Citadel Advisors
Miami,
Florida
|
$31.3K |